Bandaríkin - enska - NLM (National Library of Medicine)

advanced first aid, inc. - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - cough suppressant / oral anesthetic uses: temporarily relieves • cough as may occur with a cold • occaional minor irritation and sore throat

Bandaríkin - enska - NLM (National Library of Medicine)

advanced first aid, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - pain reliever/fever reducer with adjuvant uses: temporarily relieves minor aches and pains associated with: • headaches • colds • toothache • minor arthritis pain • muscular aches • menstrual cramps • backache

Bandaríkin - enska - NLM (National Library of Medicine)

advanced first aid, inc. - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - homeopathic cold remedy uses: - reduce the duration of the common cold - reduce the severity of cold symptoms: cough, sore throat, stuffy nose, sneezing, post nasal drip and/or hoarseness

Bandaríkin - enska - NLM (National Library of Medicine)

advanced first aid, inc. - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - cough suppressant / oral anesthetic uses: temporarily relieves • cough as may occur with a cold • occasional minor irritation and sore throat

Bandaríkin - enska - NLM (National Library of Medicine)

advanced first aid, inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - pain reliever/fever reducer with adjuvant uses: temporarily relieves minor aches and pains associated with: • headaches • colds • toothache • minor arthritis pain • muscular aches • menstrual cramps • backache

Singapúr - enska - HSA (Health Sciences Authority)

advanced ophthalmic innovations pte. ltd. - ophthalmology - for use in patients with medically uncontrollable glaucoma and poor surgical outcomes. this includes but is not limited to neovascular glaucoma, aphakic/ pseudophakic glaucoma, patients who have failed conventional surgery, congenital glaucoma and secondary glaucoma due to uveitis, epithelial downgrowth, etc.

Singapúr - enska - HSA (Health Sciences Authority)

advance healthcare pte. ltd. - ophthalmology - are sterile, preservative-free solutions in single-use dose containers, for the rehydration, lubrication and protection of the eye from dryness and irritation caused during contact lenses wear.

Bandaríkin - enska - NLM (National Library of Medicine)

advanced local health llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to decrease bacteria on the skin when water, soap & towel are not available – recommended for repeated use.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - bortezomib, quantity: 3.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - bortezomib, quantity: 2.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.